CND Life Sciences Awarded Third NIH SBIR Grant to Study the Syn-One Test® in Patients Diagnosed with REM Sleep Behavior Disorder (RBD)
/PRNewswire/ -- CND Life Sciences, an innovative medical diagnostics company pioneering the detection, visualization, and quantification of protein deposition...
United States Mitchell Miglis Todd Levine Jen Marnowski American Prodromal Synucleinopathy Consortium Phase Ii Small Business Innovation Research
Source: prnewswire.com